Others will no doubt use the weekend to comb this
Post# of 148306
Personally....not sure what this document tells us but I don’t think it negatively impacts the HIV combo BLA mono trial, and the TNBC patient and upcoming trial.
Yes, this lawsuit will be used in the short run to bash the stock, but this lawsuit also identifies multiple suiters and banks that are interested in Leronlimab. That cannot be denied.